Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TK2 | O00142 | 7/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | PYGM | P11217 | 3/20 | 0.42 |
| ▸ | TK1 | P04183 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | SLC5A2 | P31639 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28358456 | 0.95 | CYP1A2 (0.49) | TK2CYP1A2CYP2C19CYP2C9KMT2A | |
| SCHEMBL17210982 | 0.93 | PYGM (0.44) | TK2PYGMTK1SLC5A2 | |
| SCHEMBL15798586 | 0.93 | PYGM (0.44) | TK2PYGMTK1SLC5A2 | |
| SCHEMBL15810682 | 0.93 | PYGM (0.44) | TK2PYGMTK1SLC5A2 | |
| SCHEMBL18870659 | 0.93 | PYGM (0.44) | TK2PYGMTK1SLC5A2 | |
| SCHEMBL19007490 | 0.93 | PYGM (0.44) | TK2PYGMTK1SLC5A2 | |
| SCHEMBL12223731 | 0.92 | CYP1A2 (0.43) | TK2CYP1A2CYP2C19CYP2C9KMT2A | |
| SCHEMBL12667540 | 0.92 | CYP1A2 (0.43) | TK2CYP1A2CYP2C19CYP2C9KMT2A | |
| SCHEMBL12667528 | 0.88 | PYGM (0.42) | TK2PYGMSLC5A2 | |
| SCHEMBL12245097 | 0.88 | PYGM (0.42) | TK2PYGMSLC5A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4569112-A1 | METHODS AND COMPOSITIONS FOR MODULATING SPLICING AT ALTERNATIVE SPLICE SITES | Remix Therapeutics Inc. (US) | 2025-06-18 | — | — | EP | disclosed |
| WO-2024035952-A1 | METHODS AND COMPOSITIONS FOR MODULATING SPLICING AT ALTERNATIVE SPLICE SITES | REMIX THERAPEUTICS INC. (US) | 2024-02-15 | — | — | WO | disclosed |
| CN-117355329-A | VLP enterovirus vaccine | 摩登纳特斯有限公司 | 2024-01-05 | — | — | CN | disclosed |